Exclusive: EU in talks with Moderna, BioNtech, CureVac to protect imaginable COVID vaccines
The European Union is negotiating early acquisition agreements for potential vaccines opposed to COVID-19 with the drug brands Moderna, Sanofi and Johnson and Johnson as biotech corporations BioNtech and CureVac, two European resources told Reuters.